GHISONI, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 2.519
EU - Europa 1.796
AS - Asia 1.565
SA - Sud America 144
OC - Oceania 37
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 6
Totale 6.101
Nazione #
US - Stati Uniti d'America 2.410
CN - Cina 741
IT - Italia 490
SG - Singapore 280
GB - Regno Unito 276
DE - Germania 170
FR - Francia 147
JP - Giappone 125
IE - Irlanda 123
BR - Brasile 103
PL - Polonia 99
ES - Italia 94
IN - India 90
SE - Svezia 86
CA - Canada 80
VN - Vietnam 66
FI - Finlandia 51
KR - Corea 40
NL - Olanda 38
TR - Turchia 38
AU - Australia 37
AT - Austria 36
HK - Hong Kong 33
TW - Taiwan 32
MX - Messico 25
BE - Belgio 24
CH - Svizzera 24
ID - Indonesia 23
UA - Ucraina 21
PT - Portogallo 18
TH - Thailandia 18
IL - Israele 16
IR - Iran 15
DK - Danimarca 13
PE - Perù 13
RO - Romania 13
GR - Grecia 12
RU - Federazione Russa 12
CZ - Repubblica Ceca 11
HU - Ungheria 11
AR - Argentina 9
CO - Colombia 9
SA - Arabia Saudita 9
TN - Tunisia 8
EG - Egitto 7
CL - Cile 6
NO - Norvegia 6
UZ - Uzbekistan 6
BD - Bangladesh 5
KW - Kuwait 5
MY - Malesia 5
PK - Pakistan 5
ZA - Sudafrica 5
AP - ???statistics.table.value.countryCode.AP??? 4
EC - Ecuador 4
HR - Croazia 4
LT - Lituania 4
MA - Marocco 4
AM - Armenia 3
BG - Bulgaria 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
RS - Serbia 3
SD - Sudan 3
BF - Burkina Faso 2
BY - Bielorussia 2
EE - Estonia 2
EU - Europa 2
IQ - Iraq 2
JO - Giordania 2
CU - Cuba 1
JM - Giamaica 1
KE - Kenya 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 6.101
Città #
Chandler 246
Fairfield 205
Singapore 140
Ashburn 127
Santa Clara 122
Dublin 113
Beijing 105
Houston 104
Woodbridge 103
Seattle 92
Ann Arbor 89
Cambridge 81
Wilmington 80
Redwood City 78
Shanghai 68
Torino 63
Guangzhou 44
Nanjing 44
Milan 42
Warsaw 40
Nyköping 39
London 34
New York 32
Tokyo 32
Columbus 31
Fremont 30
Rome 30
Hangzhou 29
Los Angeles 29
Dong Ket 28
Helsinki 27
Medford 26
Pisa 25
Munich 24
Princeton 24
Boardman 23
São Paulo 23
Jakarta 22
Dearborn 21
Jacksonville 21
Delhi 19
Wuhan 19
Taipei 17
Turin 17
Vienna 17
Chengdu 16
Jinan 16
Hong Kong 15
Barcelona 14
Poznan 14
San Diego 14
Düsseldorf 13
Silver Spring 13
Chicago 12
Ottawa 12
Bologna 11
Boston 11
Changsha 11
Gothenburg 11
Nuremberg 11
Tianjin 11
Villeurbanne 11
Birmingham 10
Harbin 10
Hefei 10
Zhengzhou 10
Amsterdam 9
Hanoi 9
Kunming 9
Madrid 9
Manchester 9
Qingdao 9
Seoul 9
St Louis 9
Xian 9
Ankara 8
Bangkok 8
Basingstoke 8
Berlin 8
Central District 8
Duncan 8
Glasgow 8
Hanamkonda 8
Naples 8
The Dalles 8
Valencia 8
Washington 8
Brasília 7
Brussels 7
Copenhagen 7
Hamburg 7
Hyderabad 7
Lauterbourg 7
Lima 7
Lisbon 7
Nanchang 7
Oxford 7
Philadelphia 7
Phoenix 7
Riverton 7
Totale 3.149
Nome #
PARP Inhibitors in Ovarian Cancer 2.812
Checkpoint inhibitors in endometrial cancer: Preclinical rationale and clinical activity 250
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018 228
Androgen receptor status predicts development of brain metastases in ovarian cancers 217
Deficiencies in health-related quality of life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016 181
Are cyclin-dependent kinases 4/6 inhibitors ready for prime time in estrogen-receptor positive metastatic breast cancer? 167
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy 150
A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience 147
Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer 145
Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications 144
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience 144
TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers 140
Assays of conventional chemotherapeutics and targeted drugs for ovarian cancer using patient derived models 131
Reprogramming T-cells for adoptive immunotherapy of ovarian cancer 129
Immune checkpoint inhibitors in epithelial ovarian cancer: An overview on efficacy and future perspectives 125
Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series 121
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018 118
Ovarian cancer immunotherapy: Turning up the heat 103
Role of cyclin-dependent kinase inhibitors in endometrial cancer 97
Women with synchronous or metachronous lung and ovarian cancer: A multi-institutional report 95
Role of Mediterranean diet in preventing platinum based gastrointestinal toxicity in gynecolocological malignancies: A single Institution experience 91
Safe Use of Carfilzomib in a Patient with Multiple Myeloma and Intermittent Type 1 Brugada ECG Pattern: A Case Report 87
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers 81
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018 80
Veliparib: a new therapeutic option in ovarian cancer? 76
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study 59
Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience 45
763P Treatment response to non-platinum therapies in ovarian cancer patients according to BRCA status: A retrospective analysis of a large multicentric cohort 27
Totale 6.190
Categoria #
all - tutte 14.860
article - articoli 0
book - libri 0
conference - conferenze 399
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.259


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.251 31 79 151 118 108 109 89 105 99 120 84 158
2021/20221.125 88 72 63 89 91 93 102 106 89 79 142 111
2022/20231.100 87 87 55 81 110 173 90 95 130 53 77 62
2023/2024935 93 118 45 86 81 77 70 62 26 100 75 102
2024/20251.040 34 41 56 84 227 108 36 74 138 73 81 88
2025/202626 26 0 0 0 0 0 0 0 0 0 0 0
Totale 6.190